Pharmaceutical composition for the treatment of inflammatory...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/21 (2006.01) A61K 9/00 (2006.01) A61K 9/48 (2006.01) A61K 31/34 (2006.01)

Patent

CA 2304516

Inflammatory bowel disease and irritable bowel syndrome are treated by oral or rectal administration to a patient of an effective amount of a nitric oxide or a nitric oxide donor or physiologically acceptable derivative thereof. Preferably, the active compound is glyceryl trinitrate.

La maladie intestinale inflammatoire et le syndrome du côlon irritable sont traités par l'administration orale ou rectale à un patient d'une quantité efficace d'un oxyde nitrique ou d'un donneur d'oxyde nitrique ou d'un dérivé physiologiquement acceptable de ces derniers. De préférence, le composé actif est le glycéryl trinitrate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition for the treatment of inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for the treatment of inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for the treatment of inflammatory... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1734335

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.